Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam

被引:15
作者
Kaljee, Linda M. [1 ]
Pham, Van
Son, Nguyen Dinh
Hoa, Nguyen Thai
Thiem, Vu Dinh
Canh, Do Gia
Kim Thoa, Le Thi
Ali, Mohammad
Ochiai, Rion Leon
Danovaro-Holliday, M. Carolina
Acosta, Camilo J.
Stanton, Bonita
Clemens, John
机构
[1] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[3] Prov Prevent Med Ctr, Hue City, Thua Thien, Vietnam
[4] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[5] Ha Noi Med Univ, Hanoi, Vietnam
[6] Int Vaccine Inst, Seoul, South Korea
[7] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA
关键词
children/adolescents; enteric disease; vaccination; typhoid fever; Viet Nam;
D O I
10.1111/j.1365-3156.2006.01751.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES To identify demand for Vi typhoid fever vaccine for school-age children; obstacles and enabling factors for vaccine delivery; and socio-behavioural factors associated with trial participation and possible predictors of future vaccine acceptance, in Hue City, Viet Nam. METHODS Pre- and post-trial surveys of randomly selected households with children aged 6-17 years. Simple multinomial logistic analyses for ratios of relative risks (RRR) and significance on trial participation by demographics and variables related to typhoid fever, vaccination, and pre-trial experiences with information and consents. Multiple logistic regressions to assess differences in participation based on child's characteristics. RESULTS As many as 62.6% of households let all school age children participate, 10.2% let some participate, and 26.8% let none of their children participate in the trial. Factors associated with all children participating included past use of healthcare facilities (RRR, 0.45; 95% CI, 0.24-0.83), knowledge of vaccines (RRR, 0.17; 95% CI, 0.03-0.86), and perceived causes of typhoid fever (RRR, 0.90; 95% CI, 0.81-0.99). Factors associated with some children participating included utilization of healthcare facilities (RRR, 0.08; 95% CI, 0.01-0.66) and perceived severity of typhoid fever (RRR, 0.64; 95% CI 0.46-0.88). Participation was associated with satisfaction regarding pre-vaccination information and consent procedures. Children and adolescents were active decision-makers. Only 14 of 461 (2.2%) respondents would not use the Vi vaccine in the future for their child(ren). CONCLUSIONS Inter-related factors contribute to participation in a clinical vaccine trial, which may differ from desire to participate in a public health campaign. Educational campaigns need to be targeted to children and adolescents, and consideration for assent procedures for minors. Obtaining informed consent may affect trial participation within a social and political system unaccustomed to these procedures.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 33 条
[1]  
ALI M, IN PRESS HLTH PLACE
[2]   Evaluating new vaccines for developing countries - Efficacy or effectiveness? [J].
Clemens, J ;
Brenner, R ;
Rao, M ;
Tafari, N ;
Lowe, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (05) :390-397
[3]  
Clemens JD, 2004, J HEALTH POPUL NUTR, V22, P223
[4]  
Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
[5]   Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia [J].
DeRoeck, D ;
Clemens, JD ;
Nyamete, A ;
Mahoney, RT .
VACCINE, 2005, 23 (21) :2762-2774
[6]   Obstacles to influenza immunization in primary care [J].
Doran, T ;
McCann, R .
JOURNAL OF PUBLIC HEALTH MEDICINE, 2001, 23 (04) :329-334
[7]  
Engels EA, 2000, COCHRANE DB SYST REV, V2
[8]  
Evans M, 2001, BRIT J GEN PRACT, V51, P904
[9]   Third-party informed consent in research with adolescents: The good, the bad and the ugly [J].
Geluda, K ;
Bisaglia, JB ;
Moreira, V ;
Maldonado, BM ;
Cunha, AJLA ;
Trajman, A .
SOCIAL SCIENCE & MEDICINE, 2005, 61 (05) :985-988
[10]   Experience with Salmonella typhi Vi capsular polysaccharide vaccine [J].
Hessel, L ;
Debois, H ;
Fletcher, M ;
Dumas, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (09) :609-620